A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that ...
News-Medical.Net on MSN6d
Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liverPancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...
The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.
A new study led by researchers at the University of Cambridge has revealed the mechanism behind how aspirin could reduce ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET ...
A study published in Nature suggests that Asprin enhances the immune response against cancer metastasis in mice. Dr Harvey Roweth, a cancer biologist at the University of Reading, said: ...
Zacks.com on MSN1d
EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCCThe EC approves BMY's combination of Opdivo and Yervoy for the first-line treatment of adult patients with unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback